{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:49:51Z","timestamp":1777949391374,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,3]]},"DOI":"10.7759\/cureus.108196","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:40:08Z","timestamp":1777851608000},"source":"Crossref","is-referenced-by-count":0,"title":["Navigating Anxiety Management in Myasthenia Gravis Crisis With Prolonged Corrected QT (QTc): A Case Report"],"prefix":"10.7759","author":[{"given":"Garrison","family":"Burky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"QTc prolongation with antidepressants and antipsychotics","volume":"40","author":"Dietle A","year":"2015","unstructured":"Dietle A. QTc prolongation with antidepressants and antipsychotics. US Pharm. 2015, 40:HS34-40.","journal-title":"US Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2042098618772979","article-title":"Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence","volume":"9","author":"Rochester MP","year":"2018","unstructured":"Rochester MP, Kane AM, Linnebur SA, Fixen DR. Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence. Ther Adv Drug Saf. 2018, 9:297-308. 10.1177\/2042098618772979","journal-title":"Ther Adv Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00156","article-title":"Pathomechanisms and clinical implications of myasthenic syndromes exacerbated and induced by medical treatments","volume":"13","author":"Krenn M","year":"2020","unstructured":"Krenn M, Grisold A, Wohlfarth P, Rath J, Cetin H, Koneczny I, Zimprich F. Pathomechanisms and clinical implications of myasthenic syndromes exacerbated and induced by medical treatments. Front Mol Neurosci. 2020, 13:156. 10.3389\/fnmol.2020.00156","journal-title":"Front Mol Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071537","article-title":"Drugs that induce or cause deterioration of myasthenia gravis: an update","volume":"10","author":"Sheikh S","year":"2021","unstructured":"Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021, 10:1537. 10.3390\/jcm10071537","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08672","article-title":"Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation","volume":"75","author":"Beach SR","year":"2014","unstructured":"Beach SR, Kostis WJ, Celano CM, Januzzi JL, Ruskin JN, Noseworthy PA, Huffman JC. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry. 2014, 75:e441-9. 10.4088\/JCP.13r08672","journal-title":"J Clin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4685-7","article-title":"A comparative study of QT prolongation with serotonin reuptake inhibitors","volume":"234","author":"Ojero-Senard A","year":"2017","unstructured":"Ojero-Senard A, Benevent J, Bondon-Guitton E, et al.. A comparative study of QT prolongation with serotonin reuptake inhibitors. Psychopharmacology (Berl). 2017, 234:3075-81. 10.1007\/s00213-017-4685-7","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/489560-navigating-anxiety-management-in-myasthenia-gravis-crisis-with-prolonged-corrected-qt-qtc-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:40:09Z","timestamp":1777851609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/489560-navigating-anxiety-management-in-myasthenia-gravis-crisis-with-prolonged-corrected-qt-qtc-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.108196","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,3]]}}}